The TGIF2LY gene encodes a protein that is divergent at its C-terminus from its chromosome X homolog, TGIF2LX. This divergence suggests that TGIF2LY may act as a regulator of TGIF2LX . The protein encoded by TGIF2LY is involved in transcription regulation and may have a specific role in the testis .
TGIF2LY is believed to play a role in transcription regulation, particularly in the testis. It may act as a competitor or regulator of TGIF2LX, influencing various biological processes . The gene is associated with certain diseases, such as Autosomal Recessive Pyridoxine-Refractory Sideroblastic Anemia 2 .
The human recombinant form of TGIF2LY is produced using recombinant DNA technology, which involves inserting the TGIF2LY gene into a suitable expression system to produce the protein in vitro. This recombinant protein can be used for various research and therapeutic purposes, including studying its function and potential role in diseases.
Research on TGIF2LY has shown its involvement in various cellular processes. For example, phosphorylation of TGIF2 has been identified as a therapeutic target in lung adenocarcinoma, where it drives epithelial-mesenchymal transition (EMT) and metastasis . This highlights the potential of TGIF2LY as a target for cancer therapy.